Get informed when a big investor buys or sells
+ FollowOvervalued by 116.6% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $3.01 Billion |
|---|---|
| Enterprise Value | $3.20 Billion |
| Earnings per Share | $-0.19 |
| Beta | 0.69 |
| Outstanding Shares | 334,893,286 |
| P/E Ratio | 52.24 |
|---|---|
| PEG | -22.29 |
| Price to Sales | 2.25 |
| Price to Book Ratio | 3.0 |
| Enterprise Value to Revenue | 2.35 |
| Enterprise Value to EBIT | 44.76 |
| Enterprise Value to Net Income | 56 |
| Total Debt to Enterprise | 0.16 |
| Debt to Equity | 0.46 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Zhuhai Rundu Pharmaceutical Co., Ltd., a pharmaceutical firm established in 1997 and based in Zhuhai, China, is engaged in the research, production, and worldwide distribution of pharmaceutical components. The company's diverse portfolio...